Müller C1, Bunka M2, Haller S3, Köster U4, Groehn V5, Bernhardt P6, van der Meulen N7, Türler A2, Schibli R8.
J Nucl Med. 2014 Oct;55(10):1658-64. doi: 10.2967/jnumed.114.141614. Epub 2014 Jul 17.In recent years, (47)Sc has attracted attention because of its favorable decay characteristics (half-life, 3.35 d; average energy, 162 keV; Eγ, 159 keV) for therapeutic application and for SPECT imaging. The aim of the present study was to investigate the suitability of (47)Sc for radionuclide therapy in a preclinical setting. For this purpose a novel DOTA-folate conjugate (cm10) with an albumin-bi ... Read More